Biophytis Company
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
Technology:
Geroscience
Industry:
Drug Development
Headquarters:
Paris, Ile-de-France, France
Founded Date:
1/1/2006
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
4
Total Funding:
$14.9M
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership